Skip to main content
Premium Trial:

Request an Annual Quote

New Product Watch: Apr 12, 2011


Affymetrix this week launched its Axiom Genome-Wide CHB 1 Array, which is designed to characterize the genetic basis of disease in Han Chinese populations.

To design the array, researchers at the Bio-X Center of Shanghai Jiao Tong University and Beijing's Fuwai Hospital selected content from Affy's Axiom Genomic Database as well as Han Chinese data made available through the International HapMap Project.

According to Affy, the arrays will allow researchers to "better match cases and controls within ethnic groups so they focus only on differences by disease state, not structural differences between populations." The firm is marketing the tool to customers "interested in exploring the genetic complexities underlying disease in Han Chinese populations and in populations of Chinese descent."

Asuragen this week launched Inform Thyroid, a panel of molecular markers used on fine needle aspirates of thyroid nodules to aid physicians in the management of thyroid cancer. The FNAs are analyzed on Luminex's xMap platform.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.